lapozan 5 mg mutē disperģējamās tabletes
medochemie ltd., cyprus - olanpazīns - mutē disperģējamās tabletes - 5 mg
lapozan 10 mg mutē disperģējamās tabletes
medochemie ltd., cyprus - olanpazīns - mutē disperģējamās tabletes - 10 mg
lapozan 15 mg mutē disperģējamās tabletes
medochemie ltd., cyprus - olanpazīns - mutē disperģējamās tabletes - 15 mg
lapozan 5 mg apvalkotās tabletes
medochemie ltd., cyprus - olanpazīns - apvalkotā tablete - 5 mg
lapozan 10 mg apvalkotās tabletes
medochemie ltd., cyprus - olanpazīns - apvalkotā tablete - 10 mg
cyclavance
virbac, francija - ciclosporin - šķīdums iekšķīgai lietošanai - 100 mg/ml - kaķi; suņi
visulingual® lingual (2021.) šķidrums
sia „hbo pie ran firma vita” - šķidrums
zeposia
bristol-myers squibb pharma eeig - ozanimod hidrohlorīds - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imūnsupresanti - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
ponvory
janssen-cilag international n.v. - ponesimod - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
byannli (previously paliperidone janssen-cilag international)
janssen-cilag international n.v. - paliperidona palmitāts - Šizofrēnija - psihoterapija - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.